1.
J Am Heart Assoc
; 11(23): e027618, 2022 12 06.
Article
in English
| MEDLINE
| ID: mdl-36382968
ABSTRACT
Hypertrophic cardiomyopathy is the most common genetic heart disease. Biomarkers, molecules measurable in the blood, could inform the clinician by aiding in diagnosis, directing treatment, and predicting outcomes. We present an updated review of circulating biomarkers in hypertrophic cardiomyopathy representing key pathologic processes including wall stretch, myocardial necrosis, fibrosis, inflammation, hypertrophy, and endothelial dysfunction, in addition to their clinical significance.
Subject(s)
Cardiomyopathy, Hypertrophic , Humans , Cardiomyopathy, Hypertrophic/diagnosis , Cardiomyopathy, Hypertrophic/physiopathology , Biomarkers/blood
2.
Orthopedics
; 37(8): 564-7, 2014 Aug.
Article
in English
| MEDLINE
| ID: mdl-25102499
ABSTRACT
A 79-year-old woman presents with left anterior knee pain after a fall.
